María Asunción Esteve‐Pastor

Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry

Martín Ruiz Ortiz, Javier Muñiz, P Rana Miguez et al. · EP Europace · 2017 · 123 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +15

Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

David Vivas, Vanessa Roldán, María Asunción Esteve‐Pastor et al. · Revista Española de Cardiología (English Edition) · 2020 · 91 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor et al. · Thrombosis and Haemostasis · 2017 · 86 citations

Medicine, Cardiology, Pharmacotherapy +17

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Alena Shantsila et al. · Thrombosis and Haemostasis · 2017 · 61 citations

Medicine, Cardiology, Preventive Cardiology +16

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

José Miguel Rivera‐Caravaca, Juan A. Vílchez, Josefa Gálvez et al. · Stroke · 2019 · 61 citations

Medicine, Cardiology, Clinical Pharmacology +16